PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
11257268-2	2001	Functional genetic variants of the MS may alter total homocysteine (tHcy) as well as folate levels which are independent risk factors for vascular disease.	thcy	68-72	5-methyltetrahydrofolate-homocysteine methyltransferase	Homo sapiens	35-37	
11257268-3	2001	The influence of a common genetic polymorphism (2756A-->G, D919G) of the MS gene on plasma tHcy and folate levels and its relation to the risk of myocardial infarction (MI) in a prospective study of male physicians in the US was investigated.	thcy	94-98	5-methyltetrahydrofolate-homocysteine methyltransferase	Homo sapiens	76-78	
11257268-8	2001	The MS polymorphism was associated with decreased tHcy (10.55, 9.87 and 9.57 nmol/ml for DD, DG and GG genotypes, respectively) and increased folate levels (3.95, 3.78, 7.31 ng/ml for DD, DG and GG genotypes, respectively) only among controls but not cases.	thcy	50-54	5-methyltetrahydrofolate-homocysteine methyltransferase	Homo sapiens	4-6	
11257268-9	2001	It was concluded that influence of the MS (D919G) polymorphism on the plasma tHcy and folate levels is at most moderate, but should be further investigated in other large prospective studies.	thcy	77-81	5-methyltetrahydrofolate-homocysteine methyltransferase	Homo sapiens	39-41